|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
A Phase II Study Evaluating
Bevacizumab in Combination with Fixed-Dose Rate Gemcitabine and
Low-Dose Cisplatin for Metastatic Pancreatic Cancer: Is an Anti-VEGF
Strategy Still Applicable? Invest New Drugs. 2008 Apr 1.
[Epub] PMID: 18379729 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |